Loading...

JOURNAL OF BLOOD DISORDERS AND MALIGNANCIES

About the Journal

Recently Published Articles

Research

Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia

Corresponding Author: Brian M. Barth, University of Alaska Southeast , Department of Natural Sciences , 11066 Auke Lake Way , Anderson 205F , United States.
Pdf Full text Views (764)

Review Article

Lymphoproliferative Disorders in Young Adults: Review

Corresponding Author: Firas Hussein, Tishreen University Hospital, Department of Clinical Hematology, Tishreen Street, Lattakia, Syrian Arab Republic.
Pdf Full text Views (1874)

Review Article

Update on Novel Therapy of Relapsed Multiple Myeloma

Corresponding Author: Nahla A. M. Hamed, Faculty of Medicine Alexandria University, Department of Clinical Hematology, Professor, Alexandria, University, Egypt.
Pdf Full text Views (2591)

Case Report

Trousseau's Syndrome: A Case Report

Corresponding Author: Mónica Sofia Pinho, Centro Hospitalar de Entre o Douro e Vouga Rua Dr. Cândido de Pinho, Resident of Medical Oncology Department of Medical Oncology, Portugal.
Pdf Full text Views (5325)

Editorial Team

Welcome to the Journal of Blood Disorders and Malignancies

The Journal of Blood Disorders and Malignancies is an authoritative source for the latest research and developments in the field of hematology. Our journal is committed to advancing the understanding, diagnosis, treatment, and prevention of blood disorders and hematologic malignancies. We serve as a vital resource for clinicians, researchers, and healthcare professionals dedicated to improving patient outcomes in this critical area of medicine.

Our Mission

Our mission is to enhance the scientific and clinical understanding of blood disorders and malignancies by providing a platform for high-quality, peer-reviewed research. We aim to facilitate the translation of basic research findings into clinical applications, ultimately improving patient care and outcomes.

Journal Focus

The Journal of Blood Disorders and Malignancies covers a broad spectrum of topics within hematology, including but not limited to:

  • Hematologic Malignancies: Research on leukemia, lymphoma, myeloma, and other blood cancers, including their pathophysiology, diagnosis, and treatment.

  • Non-Malignant Blood Disorders: Studies on anemia, thrombocytopenia, hemophilia, and other non-malignant blood disorders, focusing on their underlying mechanisms and therapeutic approaches.

  • Stem Cell and Bone Marrow Transplantation: Advances in stem cell biology, transplantation techniques, and post-transplant care for patients with blood disorders and malignancies.

  • Hematopoiesis and Blood Cell Function: Insights into the processes of blood cell formation and function, including the regulation of hematopoiesis and the role of different blood cell types.

  • Coagulation and Hemostasis: Research on the mechanisms of blood clotting, bleeding disorders, and the development of anticoagulant therapies.

  • Genetics and Genomics: Studies on the genetic and genomic alterations associated with blood disorders and malignancies, including their implications for diagnosis and treatment.

  • Innovative Therapies: Exploration of new and emerging therapies, including targeted treatments, immunotherapies, and personalized medicine approaches.

  • Clinical Trials and Case Studies: Reports on clinical trials, novel treatment protocols, and case studies that provide insights into the practical application of research findings.

Join Our Community

We invite researchers, clinicians, and healthcare professionals to join our community. Stay informed about the latest advancements in hematology, share your research, and collaborate with peers to drive innovation and improve patient care in the field of blood disorders and malignancies.

Submit Your Research

The Journal of Blood Disorders and Malignancies welcomes submissions of original research articles, review papers, case reports, and clinical studies that contribute to the understanding and treatment of blood disorders and hematologic malignancies. Share your findings with a global audience and help advance the field of hematology.

Conclusion

Thank you for choosing the Journal of Blood Disorders and Malignancies as your trusted source for the latest research and developments in hematology. Together, we can make significant progress in the diagnosis, treatment, and prevention of blood disorders and malignancies, ultimately improving patient outcomes and quality of life.

Aims and Scope

Aims:

  1. Advancing Scientific Knowledge: Our aim is to publish high-quality, peer-reviewed research that enhances the understanding of blood disorders and malignancies, contributing to scientific advancements and clinical practice.

  2. Improving Clinical Outcomes: We strive to support the translation of research findings into clinical applications, thereby improving the diagnosis, treatment, and management of patients with hematologic conditions.

  3. Facilitating Interdisciplinary Collaboration: We aim to foster collaboration among researchers, clinicians, and healthcare professionals across various disciplines to address the complex challenges associated with blood disorders and malignancies.

  4. Promoting Innovation: Our goal is to highlight innovative research and emerging therapies that have the potential to revolutionize the field of hematology and improve patient care.

Scope:

The scope of the Journal of Blood Disorders and Malignancies includes a wide range of topics related to hematology, such as:

  • Hematologic Malignancies: Leukemia, lymphoma, myeloma, and other blood cancers, including their pathophysiology, genetic and molecular basis, diagnostic techniques, and treatment options.

  • Non-Malignant Hematology: Disorders such as anemia, thrombocytopenia, hemophilia, sickle cell disease, and other non-malignant blood conditions, with a focus on their underlying mechanisms and therapeutic strategies.

  • Stem Cell Research and Transplantation: Innovations in stem cell biology, bone marrow transplantation, and cellular therapies, including techniques to enhance engraftment and reduce transplant-related complications.

  • Blood Cell Development and Function: Research on the biology of hematopoiesis, the regulation of blood cell development, and the functional roles of different blood cell types in health and disease.

  • Coagulation and Bleeding Disorders: Studies on the mechanisms of coagulation, the pathophysiology of bleeding disorders, and the development of new anticoagulant and hemostatic agents.

  • Genetic and Genomic Research: Investigations into the genetic and genomic alterations that contribute to blood disorders and malignancies, including their implications for personalized medicine and targeted therapies.

  • Clinical and Translational Research: Clinical trials, case reports, and translational studies that bridge the gap between laboratory research and clinical practice, highlighting new treatment protocols and patient management strategies.

Through our comprehensive aims and scope, the Journal of Blood Disorders and Malignancies seeks to be a leading resource for the latest research, clinical practices, and educational advancements in the field of hematology.

Subjects covered by the Journal of Blood Disorders and Malignancies

  • Precision hematology
  • Clinical platelet disorders
  • Hematopoiesis
  • Red blood cell and iron disorders
  • White blood cell disorders
  • Bone marrow failure syndromes
  • Polycythemia/erythrocytosis
  • Autoimmune blood cell disorders
  • Thrombosis and anticoagulation disorders
  • T-cell malignancies
  • Blood cancers
  • Myeloproliferative neoplasms
  • Megakaryocytes to platelets in health and disease
  • Advances in cell-based immune therapeutics in hematology
  • Transcription factors in hematopoiesis and hematologic disease
  • Leukemic stem cells
  • Blood disorders risk factor
  • Blood disorders prevention and treatment
  • T-cell malignancies
  • Blood cancers
  • Myeloproliferative neoplasms
  • Genome editing in hematology
  • Megakaryocytes to platelets in health and disease
  • Genome editing in hematology

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism

Retractions

Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.

Feedback

We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org